The central theme of the first edition in 2017 was an introduction to the biotechnology ecosystems in Boston and Paris, which were also highlighted in terms of innovation and leadership.
The Summit®’s framework for its 2018 edition was “from the promise of raising capital to the reality of clinical trials” and featured speakers from the academic, biotech, investor, legal/regulatory and pharma worlds. A CEO “pitching session” was introduced.
The objective of the third Summit in 2019 held at The Wistar Institute was to further ensure that it could offer an efficient and cost-effective forum which will add value for the companies taking part. To achieve this, the organizers’ aim was to maintain a rich content and a “human size” and to strategically expand this US-based Summit® to broader European participation. An International Program Committee was also set up.
In 2020, the Summit stepped up to contribute during the Covid-19 Pandemic, That year was fully dedicated to discuss Epidemiology, Treatment, and Prevention.
In 2021, the Summit focused on New Skills in Biotechnology, and New Investments in Health.